Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-07-5564PMID 18172321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia-inducible factors in stem cells and cancer

  2009cited by this paper
• Hypoxia and cancer

  2007cited by this paper
• Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy

  2006cited by this paper
• Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective

  2006cited by this paper
• Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments

  2006cited by this paper
• The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.

  2006cited by this paper
• HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.

  2006cited by this paper
• Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.

  2005cited by this paper
• Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

  2005cited by this paper
• Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies.

  2005cited by this paper
• Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

  2004cited by this paper
• Vascular endothelial growth factor: basic science and clinical progress.

  2004cited by this paper
• VEGF receptor signal transduction.

  2003cited by this paper
• Clinical translation of angiogenesis inhibitors

  2002cited by this paper
• Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor binding

  2002cited by this paper
• VEGF Receptor Signal Transduction

  2001cited by this paper
• Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.

  2001cited by this paper
• A single autophosphorylation site on KDR/Flk‐1 is essential for VEGF‐A‐dependent activation of PLC‐γ and DNA synthesis in vascular endothelial cells

  2001cited by this paper
• VEGF nuclear accumulation correlates with phenotypical changes in endothelial cells.

  2000cited by this paper
• Neuropilin‐1 expression by tumor cells promotes tumor angiogenesis and progression

  2000cited by this paper
• Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis

  2000cited by this paper
• VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells

  1999cited by this paper
• Wild-type p53 is not sufficient for serum starvation-induced apoptosis in cancer cells but accelerates apoptosis in sensitive cells.

  1997cited by this paper
• Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

  1996cited by this paper

• Pseudohypoxia induced by chemical pollutants: Biochemical evidence of environmental vulnerability.

  2025cites this paper
• Enhancing Colorectal Cancer Treatment Through VEGF/VEGFR Inhibitors and Immunotherapy

  2025cites this paper
• Ultrasound‐Assisted Synthesis of Novel Chromone‐Based Thiosemicarbazone Derivatives as Potential Anticancer Agents and Their Apoptotic, Cell Cycle, Autophagy, Molecular Docking, and ADMET Prediction Studies

  2025cites this paper
• Novel Schiff bases of quinolin-4(1h)-one: Synthesis, antiproliferative evaluation, apoptosis, cell cycle, autophagy and molecular docking studies in human colon cancer cells

  2024cites this paper
• Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells

  2023cites this paper
• Vitamin D and Hypoxia: Points of Interplay in Cancer

  2022cites this paper
• Novel Drugs with High Efficacy against Tumor Angiogenesis

  2022cites this paper
• Specific Inhibition of HIF Activity: Can Peptides Lead the Way?

  2021cites this paper
• Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics

  2020cites this paper
• The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis

  2020cites this paper
• Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.

  2019cites this paper
• YY1 Promotes Endothelial Cell-Dependent Tumor Angiogenesis in Hepatocellular Carcinoma by Transcriptionally Activating VEGFA

  2019cites this paper
• Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells

  2019cites this paper
• Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway

  2018cites this paper
• Hypoxia and hypoxia-inducible factors in neuroblastoma

  2017cites this paper
• Hypoxia, pseudohypoxia and cellular differentiation.

  2017cites this paper
• Le phénotype mésenchymateux et la réponse aux agents anti-VEGF dans le cancer colorectal

  2017cites this paper
• Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

  2017cites this paper
• Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells

  2017cites this paper
• Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.

  2016cites this paper
• Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.

  2016cites this paper
• Penetration and Silencing Activity of VEGF Dicer Substrate siRNA Vectorized by Chitosan Nanoparticles in Monolayer Culture and a Solid Tumor Model In Vitro for Potential Application in Tumor Therapy

  2016cites this paper
• Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection

  2016cites this paper
• High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab

  2016cites this paper
• Tumour Hypoxia and the Hypoxia-Inducible Transcription Factors: Key Players in Cancer Progression and Metastasis

  2015cites this paper
• HIF-1α in colorectal carcinoma: review of the literature.

  2015cites this paper
• Microenvironment and Immunology Tumor-Derived GM-CSF Promotes In fl ammatory Colon Carcinogenesis via Stimulating Epithelial Release of VEGF

  2014cites this paper
• Tumor-derived GM-CSF promotes inflammatory colon carcinogenesis via stimulating epithelial release of VEGF.

  2014cites this paper
• VEGF and colon cancer growth beyond angiogenesis: does VEGF directly mediate colon cancer growth via a non-angiogenic mechanism?

  2014cites this paper
• Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models

  2014cites this paper
• Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor

  2014influential citation
• Functional analysis of angiogenic factors in tumor cells and endothelia Funktionelle Analyse angiogener Faktoren in Tumorzellen und Endothelien

  2014cites this paper
• Influence d’inhibiteurs tyrosine kinase sur la biologie et la survie de cellules de cancer colorectal

  2014influential citation
• Angiogenic molecular signature in colorectal cancer: Pharmacogenomic implications for the use of antiangiogenic therapies

  2014cites this paper
• Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells

  2013cites this paper
• Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response

  2013cites this paper
• Chronic inhibition of tumor cell-derived VEGF enhances the malignant phenotype of colorectal cancer cells

  2013cites this paper
• Investigating the Antiproliferative Activity of High Affinity DNA Aptamer on Cancer Cells

  2013cites this paper
• The Decrease of Mineralcorticoid Receptor Drives Angiogenic Pathways in Colorectal Cancer

  2013influential citation
• Aberrant, ectopic expression of VEGF and VEGF receptors 1 and 2 in malignant colonic epithelial cells. Implications for these cells growth via an autocrine mechanism.

  2013cites this paper
• Functions and Clinical Implications of Autocrine VEGF Signaling in Colorectal Cancer

  2013cites this paper
• Anti-Angiogenic Therapy Combined with Chemoradiotherapy for Patients with Localized Advanced Rectal Cancer

  2013cites this paper
• Hypoxic Adaptation and Arsenic Trioxide Treatment in Small Cell Lung Carcinoma

  2013cites this paper
• Biomarkers for Renal Cell Carcinoma

  2012cites this paper
• Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer

  2012cites this paper
• Canine Mast Cell Tumours: Characterization of Subcutaneous Tumours and Receptor Tyrosine Kinase Profiling

  2012cites this paper
• Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species

  2012cites this paper
• Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.

  2012cites this paper
• Tie2-dependent knockout of HIF-1 impairs burn wound vascularization and homing of bone marrow-derived angiogenic cells.

  2012cites this paper
• Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A

  2012cites this paper
• Oxygen-dependent regulation of base excision repair and its role in oxidative stress tolerance and tumor therapy resistance

  2012cites this paper
• Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.

  2012cites this paper
• Probing High Affinity Sequences of DNA Aptamer against VEGF165

  2012cites this paper
• Biology of vascular endothelial growth factor and its receptors in head and neck cancer: Beyond angiogenesis

  2011cites this paper
• The expression of prolyl hydroxylase domain enzymes are up-regulated and negatively correlated with Bcl-2 in non-small cell lung cancer

  2011cites this paper
• Inhibition of VEGF induces cellular senescence in colorectal cancer cells

  2011cites this paper
• Pathophysiological response to hypoxia - from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes.

  2011cites this paper
• HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells.

  2011cites this paper
• Treatment recommendations for metastatic colorectal cancer

  2011cites this paper
• Negative regulation of hypoxic responses via induced Reptin methylation.

  2010influential citation
• Histo-proteomic profiling of formalin-fixed, paraffin-embedded tissue

  2010cites this paper
• Intracrine Vascular Endothelial Growth Factor Signaling in Survival and Chemoresistance of Human Colorectal Cancer Cells

  2010cites this paper
• Role of Nitric Oxide for Modulation of Cancer Therapy Resistance

  2010cites this paper
• Targeted therapies as adjuvant treatment for early-stage colorectal cancer: first impressions and clinical questions.

  2010cites this paper
• Molecular predictors of combination targeted therapies (cetuximab, bevacizumab) in irinotecan-refractory colorectal cancer (BOND-2 study).

  2010influential citation
• Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells*

  2010cites this paper
• Antiangiogenesis agent bevacizumab blocks the promoting effect of vascular endothelial growth factor on proliferation of human hepatoma cell line HepG2: Antiangiogenesis agent bevacizumab blocks the promoting effect of vascular endothelial growth factor on proliferation of human hepatoma cell line H

  2009cites this paper
• Identification of rare cancer driver mutations by network reconstruction.

  2009cites this paper
• Macrophage Migration Inhibitory Factor Promotes Colorectal Cancer

  2009cites this paper
• Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes

  2009cites this paper
• Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases.

  2009cites this paper
• NF-κB Activation, Dependent on Acetylation/Deacetylation, Contributes to HIF-1 Activity and Migration of Bone Metastatic Breast Carcinoma Cells

  2009cites this paper
• Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab

  2009cites this paper
• Survival or Death: The Redox Paradox

  2009cites this paper
• Penetration and efficacy of VEGF siRNA using polyelectrolyte complex micelles in a human solid tumor model in-vitro.

  2009cites this paper
• Targeting the hypoxia-inducible factor (HIF) pathway in cancer

  2009cites this paper
• Vessel normalization by VEGF inhibition: a complex story

  2008cites this paper
• Hypoxia associated p38 Mitogen Activated Protein Kinase Mediated Androgen Receptor Activation and Increased Hif-1α Levels Contribute to emergence of an Aggressive Phenotype in Prostate Cancer

  2008cites this paper
• The Promise of Biological and Molecular-orientated Treatments for Colon Cancer

  2008cites this paper
• Clinical Use of Anti‐Vascular Endothelial Growth Factor Monoclonal Antibodies in Metastatic Colorectal Cancer

  2008cites this paper
• Solid tumor physiology and hypoxia-induced chemo/radio-resistance: novel strategy for cancer therapy: nitric oxide donor as a therapeutic enhancer.

  2008cites this paper
• c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets

  2008cites this paper